Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Combination treatment with hENT1 and miR-143 reverses gemcitabine resistance in triple-negative breast cancer.
Cancer Cell Int. 2022 Sep 1;22(1):271. doi: 10.1186/s12935-022-02681-0.
Cancer Cell Int. 2022.
PMID: 36050724
Free PMC article.
CircANKRD17 promotes glycolysis by inhibiting miR-143 in breast cancer cells.
Chen H, Zhang LF, Zhang L, Miao Y, Xi Y, Liu MF, Zhang M, Li B.
Chen H, et al.
J Cell Physiol. 2023 Dec;238(12):2765-2777. doi: 10.1002/jcp.31128. Epub 2023 Oct 9.
J Cell Physiol. 2023.
PMID: 37812578
Item in Clipboard
Cite
Cite